CYGB and non-small cell lung carcinoma: Furthermore, CYGB expression has recently been shown by us to be significantly downregulated in 54% sporadic non-small cell lung cancer (NSCLC) in comparison with surrounding ‘normal’ tissues (Xinarianos et al, 2006).